Intravenous Thrombolytic Therapy for Treatment of Acute Ischemic Stroke in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2022-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2022.0068PMID 35143602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.

  2022cited by this paper
• Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants

  2021cited by this paper
• Ischaemic stroke in anticoagulated patients with atrial fibrillation

  2021cited by this paper
• European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

  2021cited by this paper
• Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants: To Treat or How to Treat.

  2021cited by this paper
• Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort

  2020cited by this paper
• Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation

  2020cited by this paper
• Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases

  2020cited by this paper
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke.

  2019cited by this paper
• 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2018cited by this paper
• Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage

  2018cited by this paper
• Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice

  2017cited by this paper
• Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?

  2016cited by this paper
• Recanalization Therapies in Acute Ischemic Stroke Patients: Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Outcome

  2015cited by this paper
• Recanalization Therapies in Acute Ischemic Stroke PatientsCLINICAL PERSPECTIVES

  2015cited by this paper
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

  2014cited by this paper
• Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

  2011cited by this paper

• Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study

  2026cites this paper
• Intravenous thrombolysis in patients with recent intake of direct oral anticoagulants: A target trial analysis after the liberalization of institutional guidelines

  2024cites this paper
• Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

  2023cites this paper
• Modulation of muscarinic receptors by anisodine hydrobromide in cerebral ischemia.

  2023cites this paper